Company

Orna Therapeutics, Inc.

Orna Therapeutics develops circular RNA therapeutics and lipid nanoparticle delivery systems.

About

Founded in 2019, Orna Therapeutics develops engineered circular RNA and lipid nanoparticle delivery systems for potential treatments in oncology, autoimmune, and infectious diseases. Its technologies include oRNA® and panCAR™. In August 2022, it raised USD 121.00 mn in Series B funding led by M Ventures.

2Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in